|
| | Publication Year | Title | Author(s) |
| 1 | 1-Feb-2014 | 18F-fluorodeoxyglucose--positron emission tomography/computed tomography aids staging and predicts mortality in patients with muscle-invasive bladder cancer. | Mertens, Laura S; Mir, M Carmen; Scott, Andrew M ; Lee, Sze Ting ; Fioole-Bruining, Annemarie; Vegt, Erik; Vogel, Wouter V; Manecksha, Rustom; Bolton, Damien M ; Davis, Ian D; Horenblas, Simon; van Rhijn, Bas W G; Lawrentschuk, Nathan |
| 2 | Oct-2016 | 24-month durability after crossover to the prostatic urethral lift from randomised, blinded sham | Rukstalis, Daniel; Rashid, Prem; Bogache, William; Tutrone, Ronald; Barkin, Jack; Chin, Peter; Woo, Henry; Cantwell, Anthony; Cowan, Barrett; Bolton, Damien M |
| 3 | 2023 | 3D printed patient-specific prostate cancer models to guide nerve-sparing robot-assisted radical prostatectomy: a systematic review. | Coles-Black, Jasamine ; Ong, Sean; Teh, Jiasian ; Kearns, Paul; Ischia, Joseph J ; Bolton, Damien M ; Lawrentschuk, Nathan |
| 4 | 31-Mar-2023 | 5-alpha reductase inhibitors use in prostatic disease and beyond. | Chislett, Bodie ; Chen, David; Perera, Marlon ; Chung, Eric; Bolton, Damien M ; Qu, Liang G |
| 5 | Apr-2018 | 68Ga-prostate specific membrane antigen (PSMA) positron emission tomography (PET) for primary staging of high-risk prostate cancer: a systematic review | Corfield, Julia; Perera, Marlon ; Bolton, Damien M ; Lawrentschuk, Nathan |
| 6 | Dec-2017 | 68Ga-prostate-specific membrane antigen-positron emission tomography/computed tomography in advanced prostate cancer: Current state and future trends. | Udovicich, Cristian; Perera, Marlon ; Hofman, Michael S; Siva, Shankar; Del Rio, Andres ; Murphy, Declan G; Lawrentschuk, Nathan |
| 7 | May-2019 | A blind spot in urology: Prostate cancer associated retinopathy. | Duncan, Catriona; Zamir, Ehud; Teh, Jiasian ; Joon, Daryl Lim; Liodakis, Peter |
| 8 | Nov-2019 | A contemporary, nationwide analysis of surgery and radiotherapy treatment for prostate cancer. | Roberts, Matthew J; Papa, Nathan; Perera, Marlon ; Scott, Susan; Teloken, Patrick E; Joshi, Andre; Vela, Ian; Pryor, David; Martin, Jarad; Woo, Henry |
| 9 | Nov-2019 | A Cost-effectiveness Analysis of Systemic Therapy for Metastatic Hormone-sensitive Prostate Cancer. | Sathianathen, Niranjan J; Alarid-Escudero, Fernando; Kuntz, Karen M; Lawrentschuk, Nathan; Bolton, Damien M ; Murphy, Declan G; Kim, Simon P; Konety, Badrinath R |
| 10 | Dec-2022 | A decade of declining prostatectomy margin positivity within a prostate cancer clinical quality registry. | Papa, Nathan; Perera, Marlon ; Bensley, Jonathan G; Evans, Melanie; Millar, Jeremy; Frydenberg, Mark; Murphy, Declan G; Bolton, Damien M |
| 11 | 2019 | A Review of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) in Renal Cell Carcinoma (RCC). | Ahn, Thomas; Roberts, Matthew J; Abduljabar, Aous; Joshi, Andre; Perera, Marlon ; Rhee, Handoo; Wood, Simon; Vela, Ian |
| 12 | May-2020 | A Simple Clinical Tool for Stratifying Risk of Clinically Significant CKD after Nephrectomy: Development and Multinational Validation. | Ellis, Robert J; Del Vecchio, Sharon J; Gallagher, Kevin M J; Aliano, Danielle N; Barber, Neil; Bolton, Damien M ; Chew, Etienne T S; Coombes, Jeff S; Coory, Michael D; Davis, Ian D; Donaldson, James F; Francis, Ross S; Giles, Graham G; Gobe, Glenda C; Hawley, Carmel M; Johnson, David W; Laird, Alexander; Leung, Steve; Malki, Manar; Marco, David J T; McNeill, Alan S; Neale, Rachel E; Ng, Keng L; Phipps, Simon; Stewart, Grant D; White, Victoria M; Wood, Simon T; Jordan, Susan J |
| 13 | Jul-2019 | A Simplified Frailty Index to Predict Outcomes After Radical Cystectomy. | Sathianathen, Niranjan J; Jarosek, Stephanie; Lawrentschuk, Nathan; Bolton, Damien M ; Konety, Badrinath R |
| 134 | Apr-2018 | A single institution analysis of low-dose-rate brachytherapy: 5-year reported survival and late toxicity outcomes. | Chao, Michael ; Spencer, Sandra; Guerrieri, Mario; Ding, Wei; Goharian, Mehran; Ho, Huong; Ng, Michael; Healey, Danielle; Tan, Alwin; Cham, Chee; Joon, Daryl Lim; Lawrentschuk, Nathan; Travis, Douglas; Sengupta, Shomik ; Chan, Yee ; Troy, Andrew; Pham, Trung; Clarke, David; Liodakis, Peter ; Bolton, Damien M |
| 135 | 4-Jun-2020 | A systematic scoping review of multidisciplinary cancer team and decision-making in the management of men with advanced prostate cancer. | Holmes, A; Kelly, Brian D ; Perera, Marlon ; Eapen, Renu S ; Bolton, Damien M ; Lawrentschuk, Nathan |
| 136 | 27-Jan-2021 | Accessing 3D Printed Vascular Phantoms for Procedural Simulation. | Coles-Black, Jasamine ; Bolton, Damien M ; Chuen, Jason |
| 137 | 14-Aug-2018 | Accuracy of the magnetic resonance imaging pathway in the detection of prostate cancer: a systematic review and meta-analysis. | Sathianathen, Niranjan J; Butaney, Mohit; Bongiorno, Connie; Konety, Badrinath R; Bolton, Damien M ; Lawrentschuk, Nathan |
| 138 | 1-Sep-2014 | Active surveillance in patients with a PSA >10 ng/mL. | Toren, Paul; Wong, Lih-Ming ; Timilshina, Narhari; Alibhai, Shabbir; Trachtenberg, John; Fleshner, Neil; Finelli, Antonio |
| 139 | 25-Jul-2022 | Active surveillance versus enzalutamide for low-risk prostate cancer- was it really a trial we needed? | Williams, Isabella Sc; Perera, Sachin; Murphy, Declan G; Corcoran, Niall M; Bolton, Damien M ; Lawrentschuk, Nathan |
| 140 | May-2022 | Adjuvant therapies for non-muscle-invasive bladder cancer: advances during BCG shortage. | Balasubramanian, Adithya ; Gunjur, Ashray ; Weickhardt, Andrew J ; Papa, Nathan; Bolton, Damien M ; Lawrentschuk, Nathan; Perera, Marlon |
